Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-033620

Chief Executive Officer acquired 1,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FOUSE JACQUALYN A Chief Executive Officer 2019-05-31 Option exercise +1,400 1,400 D
Derivatives
FOUSE JACQUALYN A Chief Executive Officer 2019-05-31 Option exercise · Restricted stock units −1,400 0 D
Loading xslF345X03/doc4.xml…